Pharmacies limit MDS service as lack of funding prompts safety fears

Pharmacists across Northern Ireland are no longer providing medicines trays to new patients as they fear safety will be risked by ongoing under-funding, CPNI has said.

dosetter%20tray%20shutterstock_436007986.jpg
Pharmacist Mark Hunter: We don't have the resource to provide this service to new patients safely

A number of pharmacies in Northern Ireland have been forced to withdraw their monitored dosage system (MDS) service for new patients from December because government funding for the sector falls “far below what is required to continue to safely provide” pharmacy services, Community Pharmacy Northern Ireland (CPNI) said.

Last month, Northern Ireland's Department of Health announced that community pharmacies will receive an additional £11.1 million in funding up to March 2020, but CPNI stressed that the cost of providing pharmacy services is currently under-funded “by at least £20m”.

Commenting on the decision to scrap medicines trays for new patients, CPNI chief executive Gerard Greene stressed that it is “alarming that community pharmacists feel prompted to withdraw a service. Particularly one that helps so many patients with their medicines”.

“Pharmacists now fear that taking on new patients would put both new and existing patients at risk,” he added.

“The withdrawal of the MDS service to new patients is a grassroots action by community pharmacists,” CPNI told C+D this morning (December 4).

“The sense we’re getting is the vast majority of community pharmacies [are doing this] and that it’s right across Northern Ireland.”

“Not a risk we’re willing to take”

In a statement published last week (November 29), Mark Hunter, pharmacist at Eden Pharmacy in Belfast said the pharmacy’s decision to withdraw the MDS service “has been an extremely difficult one for us to make”.

“But as health professionals, we must take difficult choices when we believe patient safety is at risk.

“As [funding] cuts deepen in our sector, pharmacists are working longer hours and with fewer staff, so we no longer have the time or resource to provide this service to new patients safely,” he added.

“The idea that someone could be put at risk by a pharmacist under pressure is not a risk we are willing to take.”

Existing MDS patients are not affected, but Mr Hunter stressed that he could not guarantee that in the long term.

Last month, Mr Greene told C+D that the “sustained funding reductions” could trigger a “snowball” of pharmacy closures. Watch the video below to find out the factors contributing to the community pharmacy crisis in Northern Ireland.

Sign in or register for free

Latest from News

RPS to become Royal College of Pharmacy after 31% voter turnout

 
• By 
 • comment0

Seven in ten Royal Pharmaceutical Society (RPS) members who took part in the ballot have voted in favour of controversial plans for the body to become a royal college and register as a charity.

New evidence Brexit caused UK medicines shortages

 
• By 
 • comment0

A health and social care think tank has revealed that the “elevated and troubling level” of medicine shortages in the UK can be blamed on Brexit.

Risk pharmacies ‘deprioritised’ if GP role grows, report warns

 
• By 
 • comment1

A Westminster think tank has said that the government’s proposed Neighbourhood Health Service, which plans to scale up general practice, could put community pharmacies at risk of being “deprioritised”.

More from Clinical

Al-Hassan: Pharmacy prescribing service ‘two or three years’ away

 
• By 
 • comment2

MP and pharmacist Sadik Al-Hassan has said the promised community pharmacy prescribing service is “deliverable” but not ready yet.

Pharmacies to boost naloxone stock amid ‘sudden’ overdose spike

 
• By 
 • comment0

Pharmacies in Scotland have been asked to ensure they have the “appropriate stock” of naloxone – a medicine used to reverse the effects of an opiate overdose – following an “increase in sudden collapse” due to overdoses.